Jefferies downgraded Karyopharm Therapeutics (NASDAQ: KPTI) from Buy to Hold with a price target of $14.00 (from $20.00).Analysts led ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE